I partner with biopharma and health tech strategy, corporate development, BD teams—and with VC/PE investors—to drive smarter decisions on their most complex deals, transformations, and competitive challenges.
I work at the intersection of strategy, transactions, and finance—helping corporate teams and investors move faster, with more conviction, on their most consequential decisions.
Julien is an exceptional economist, diplomat, and strategist. We worked together on a $450 million public health lending operation. He possesses two critical traits: non-intuitive thinking and skill in high-pressure negotiations. He is a very confident and ruthless operator.
Julien is a forward-thinking perfectionist. His work as a business and technology advisor was critical to our company's innovation success. If you're looking for a yes-man, Julien is NOT that person. He will challenge you and disagree, backed by heaps of data and research.
Julien brought a unique skill combination: expertise in therapeutic areas, technical understanding of pharmaceutical data science applications, and strong business strategy acumen. He led a year-long strategic program for Pfizer, delivering clinical development innovations.